findmyKOL
Clinical trialNCT04246671CompletedPhase 1Interventional

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

SponsorBavarian NordicEnrollment37ChordomaHER2-positive Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic - Phoenix

    Scottsdale, Arizona, United States

  • Providence Saint John'S Health Center

    Santa Monica, California, United States

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida, United States

  • H. Lee Moffitt Cancer Center

    Tampa, Florida, United States

  • Georgia Cancer Center Augusta University

    Augusta, Georgia, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Mayo Clinic - Rochester

    Rochester, Minnesota, United States

  • Providence Cancer Institute

    Portland, Oregon, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Aug 2020
Primary completion
17 Feb 2024
Completion
11 Dec 2024
Last update posted
3 Mar 2025
Registered enrollment
37
Registry id
NCT04246671

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.